Discover
BLTE
Belite Bio, Inc
142.31
2 x 113.28
2 x 183.00
bid
ask
-
11.68
7.58%
2 @ 04:00 PM
142.31 +0.00 (0.00%)
| Ytd | -11.03% | |
| 1y | 148.97% |
140.99
day range
157.99
56.10
52 week range
200.00
| Open | 153.88 | Prev Close | 153.99 | Low | 140.99 | High | 157.99 | Mkt Cap | 5.70B |
| Vol | 258.90K | Avg Vol | 189.19K | EPS | -2.54 | P/E | N/A | Forward P/E | 150.71 |
| Beta | -1.24 | Short Ratio | 5.45 | Inst. Own | 23.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 148.63 | 200-d Avg | 141.66 | 1yr Est | 210.50 |
| Income Statement | |||
| Operating Expenses | 28.08M | ||
| Research and Development Expense | 14.62M | ||
| Selling, General and Administrative Expense | 13.45M | ||
| Operating Income | -28.08M | ||
| Interest Expense | 2.00K | ||
| Net Income | -25.32M | ||
| Net Income Common Stock | -25.32M | ||
| Net Income Common Stock (USD) | -25.32M | ||
| Consolidated Income | -25.32M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -25.32M | ||
| Earning Before Interest & Taxes (USD) | -25.32M | ||
| Weighted Average Shares | 36.25M | ||
| Weighted Average Shares Diluted | 36.25M | ||
| Balance Sheet | |||
| Cash and Equivalents | 352.93M | ||
| Cash and Equivalents (USD) | 352.93M | ||
| Investments | 419.66M | ||
| Investments Current | 139.49M | ||
| Investments Non-Current | 280.17M | ||
| Trade and Non-Trade Receivables | 700.00K | ||
| Current Assets | 494.27M | ||
| Property, Plant & Equipment Net | 777.00K | ||
| Total Assets | 780.56M | ||
| Debt Current | 241.00K | ||
| Total Debt | 429.00K | ||
| Current Liabilities | 9.88M | ||
| Debt Non-Current | 188.00K | ||
| Total Liabilities | 10.07M | ||
| Accumulated Retained Earnings (Deficit) | -185.26M | ||
| Accumulated Other Comprehensive Income | -536.00K | ||
| Shareholders Equity | 770.49M | ||
| Shareholders Equity (USD) | 770.49M | ||
| Assets Non-Current | 286.28M | ||
| Total Debt (USD) | 429.00K | ||
| Goodwill and Intangible Assets | 19.00K | ||
| Liabilities Non-Current | 188.00K | ||
| Trade and Non-Trade Payables | 5.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 117.00K | ||
| Net Cash Flow from Financing | 510.12M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 195.90M | ||
| Capital Expenditure | -178.00K | ||
| Issuance (Purchase) of Equity Shares | 510.12M | ||
| Net Cash Flow from Investing | -303.73M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -303.56M | ||
| Net Cash Flow from Operations | -10.38M | ||
| Effect of Exchange Rate Changes on Cash | -101.00K | ||
| Share Based Compensation | 11.71M | ||